Professional Documents
Culture Documents
Select polymer products companies offer opportunity for shareholder value creation
December 2013
CRISIL IERIndependentEquityResearch
Assessment
Excellent fundamentals Superior fundamentals Good fundamentals Moderate fundamentals Poor fundamentals
Assessment
Strong upside (>25% from CMP) Upside (10-25% from CMP) Align (+-10% from CMP) Downside (negative 10-25% from CMP) Strong downside (<-25% from CMP)
CRISIL Privacy
CRISIL respects your privacy. We use your contact information, such as your name, address, and email id, to fulfil your request and service your account and to provide you with additional information from CRISIL and other parts of McGraw Hill Financial you may find of interest. For further information, or to let us know your preferences with respect to receiving marketing materials, please visit www.crisil.com/privacy. You can view McGraw Hill Financials Customer Privacy Policy at http://www.mhfi.com/privacy. Last updated: May, 2013
Analyst Disclosure
Each member of the team involved in the preparation of the grading report, hereby affirms that there exists no conflict of interest that can bias the grading recommendation of the company.
Disclaimer:
This Company commissioned CRISIL IER report is based on data publicly available or from sources considered reliable. CRISIL Ltd. (CRISIL) does not represent that it is accurate or complete and hence, it should not be relied upon as such. The data / report is subject to change without any prior notice. Opinions expressed herein are our current opinions as on the date of this report. Nothing in this report constitutes investment, legal, accounting or tax advice or any solicitation, whatsoever. The subscriber / user assume the entire risk of any use made of this data / report. CRISIL especially states that, it has no financial liability whatsoever, to the subscribers / users of this report. This report is for the personal information only of the authorised recipient in India only. This report should not be reproduced or redistributed or communicated directly or indirectly in any form to any other person especially outside India or published or copied in whole or in part, for any purpose.
4756
-Indexed to 100
ANALYTICAL CONTACT
Mohit Modi Bhaskar Bukrediwala Kamna Motwani Client servicing desk +91 22 3342 3561 clientservicing@crisil.com mohit.modi@crisil.com bhaskar.bukrediwala@crisil.com kamna.motwani@crisil.com
For detailed initiating coverage report please visit: www.ier.co.in CRISIL Independent Equity Research reports are also available on Bloomberg (CRI <go>) and Thomson Reuters.
CRISIL IERIndependentEquityResearch
Industry outlook
Polymer products industry reported robust growth in the past
The polymer products industry has grown at 18% CAGR over the past three years and 20% CAGR over the past five years. The industry has reported 10% volume CAGR over the past five years. Increase in polymer prices and value-added products have boosted realisations too. The industrys robust performance can be attributed to a) the substitution effect polymers (polyethylene, polypropylene, polyvinyl chloride, polystyrene, etc.) are replacing other packaging materials such as metals, glass, wood and paper due to low cost and superior properties; and b) strong demand from end-user industries such as FMCG, beverages, pharma, housing and consumer durables.
Polymers are substituting other materials due to lower cost and superior properties
Figure 1: Polymer products industry has posted 20% CAGR over FY08-13
( bn) 400 350 300 250 200 150 100 50 FY08 FY10 Polym er products industry FY13 148 211 369
Companies included: Astral Poly Technik, Bilcare, Cosmo Films, Essel Propack, Finolex Industries, Hitech Plast, Jindal Poly, Kisan Mouldings, Manjushree Technopak, Mold-Tek Packaging, Nilkamal , Pearl Polymer, Polyplex Corporation, Sintex Industries, The Supreme Industries, Time Technoplast, Uflex and Wim Plast Ltd Source: CRISIL Research
Polymer Products
Packaging: Rigid packaging polymer containers are replacing glass and tin containers used in packaging of food, beverages and also in industrial applications. This is mainly as polymer containers are easy to transport, have low breakage and are more cost effective. Flexible packaging polymers are substituting paper in flexible packaging. Lower cost of polymer pouches and better aesthetics have resulted in this transition. This is mainly witnessed in FMCG packaging. Also, packaging of certain products is moving from rigid polymers to flexible polymers as it is possible to make smaller packages if a flexible material is used. This has been observed for items such as shampoo, ketchup, etc. packaged in sachets.
Parameters (250 litres) Selling price Resale value Polymer 1,000 per drum 650-700 Steel 1,100 per drum 300-400
40% 30% 50% 20% 10% 0% Pipes Industrial containers Packaging 20% 37% 25% 40% 59%
Penetration in 2003
Penetration in 2013
CRISIL IERIndependentEquityResearch
Table 2: Products with further scope for substitution
Price differential between Industry Pipes polymer and other products 15-20% Current penetration 37% Future potential Penetration of plastic pipes in India is lower than the global average of 50%; we believe there is significant opportunity for increase in penetration Domestic penetration is 50%, leaving room for an increase. Moreover, penetration of Industrial containers 10% 50% polymer drums in Asia (ex-India) is extremely low at ~5%. Hence, there is ample opportunity for industrial packaging companies which have expanded operations to other Asian countries - e.g. Time Technoplast Packaging NA 59% CRISIL Research expects the share of polymers in the packaging industry to rise further
Polymer Products
Industry outperformers have better bargaining power compared to peers as there is a pull for their products in the market
The industry outperformers have better bargaining power compared to peers as there is a pull for their products in the market. This has enabled them to maintain profitability despite the recent weakening of demand and cost-side pressures.
Product with higher scope of penetration The Supreme Industries Finolex Industries Astral Poly Technik Essel Propack Time Technoplast
Market leader
Industry outperformers: Astral Poly Technik, Essel Propack, Finolex Industries, The Supreme Industries and Time Technoplast Others: Bilcare, Cosmo Films, Hitech Plast, Jindal Poly, Kisan Mouldings, Manjushree Technopak, Mold-Tek Packaging, Nilkamal, Pearl Polymer, Polyplex Corporation, Sintex Industries, Uflex and Wim Plast
CRISIL IERIndependentEquityResearch
Valuation
Industry outperformers have posted higher returns vs CNX 500 and other peers in the past
Over the past five years, polymer product companies have posted returns in line with the CNX 500. However, industry outperformers have posted superior returns compared to CNX 500 as well as other peers. These companies have posted a five-year return of ~600% compared to 22% decline posted by other companies. Superior earnings growth of industry outperformers has led to higher returns.
Industry outperformers have outperformed CNX 500 and other polymer companies over the past five years
150
100
50
Apr-13 May-13 May-13 Mar-13 Mar-13 Feb-13 Aug-13 Aug-13 Sep-13 Nov-13 Dec-12 Dec-13 Jun-13 Jan-13 Jan-13 Jul-13 Oct-13 Oct-13
Polymer Products
Figure 6: Industry outperformers are trading at twice the average P/E multiple of other companies
(x) 16.0 14.0 12.0 10.0 8.0 6.0 4.0 2.0 0.0
Sep-09
Sep-10
Sep-11
Sep-12
Mar-10
Mar-11
Mar-12
Mar-09
Mar-13
Jun-10
Jun-11
Jun-12
Dec-09
Dec-10
Dec-11
Dec-12
Jun-13
Dec-08
Industry outperformers
Others
Industry outperformers: Astral Poly Technik, Essel Propack, Finolex Industries, The Supreme Industries and Time Technoplast Others: Bilcare, Hitech Plast, Manjushree Technopak, Mold-Tek Packaging, Nilkamal , Sintex Industries, and Wim Plast Source: NSE, CRISIL Research
Dec-13
Jun-09
Sep-13
CRISIL IERIndependentEquityResearch
Valuation summary
M.cap NSE ticker Supreme SUPREMEIND Time JBF Dhunseri Hitech TIMETECHNO JBFIND DPTL HITECHPLAS 56,889 7,323 5,367 3,756 576 52-week 465 54 133 127 63 288 28 72 72 28 Grade 4/5 4/5 2/5 3/5 3/5 2/5 5/5 5/5 5/5 5/5 Price () 448 35 74 107 44 370 47 126 187 60 19.6 7.1 7.9 4.9 6.4 P/E 17.1 8.1 9.6 3.1 8.6 13.2 6.1 4.1 2.2 4.0 6.5 0.8 0.4 0.4 0.6 P/B 5.3 0.8 0.5 0.4 0.6 4.2 0.7 0.4 0.3 0.5 ( mn) High Low Fundamental Valuation CMP@ Fair Value FY13 FY14E FY15E FY13 FY14E FY15E
@ December 13, 2013 Sales ( mn) FY13 Supreme Time JBF Dhunseri Hitech 33,949 17,757 74,551 24,411 4,398 FY14E 40,454 21,369 83,030 40,818 4,716 FY15E 47,496 24,639 97,758 67,552 5,541 FY13 2,901 1,035 968 629 90 PAT ( mn) FY14E 3,336 909 858 1,239 67 FY15E 4,300 1,201 2,002 1,758 143 FY13 22.8 4.9 13.3 18.0 6.9 EPS ( ) FY14E 26.3 4.3 13.1 35.4 5.1 FY15E 33.9 5.7 30.7 50.2 10.8 EPS growth (%) FY13 20.5 15.2 (50.8) 323.0 -13.2 FY14E 15.0 -12.2 (1.4) 23.3 -26.2 FY15E 28.9 32.1 133.4 41.9 114 FY13 36.8 12.5 5.7 7.9 7.5 RoE (%) FY14E 34.0 9.9 5.0 13.9 5.3 FY15E 35.2 11.8 11.3 17.3 10.4
370 448
The Supreme Industries Ltd (Supreme) is Indias leading plastic products company. It has a well-diversified product portfolio comprising i) plastic piping system (50%), ii) packaging products (21%), iii) industrial products (18%) and iv) consumer products (8%). Grading rationale Supreme is one of the largest players in the PVC pipes industry. The company has kept pace with the market dynamics and has added high-potential products such as CPVC pipes and fittings in the past. Led by strong demand for plastic pipes in India due to upcoming investments in housing, replacement demand, and Supremes established position, we expect this segment to continue to drive Supremes overall growth over the next few years. It is the only Indian manufacturer of high-margin cross laminated (XF) films, a patented product of a Switzerland-based company which Supreme has licensed. Driven by its wide applications, we believe XF films have strong potential for growth in India. Supreme has an established position in its other businesses as well - protective packaging, performance films, industrial components and consumer products. We expect a majority of these businesses to continue to grow in line with end-user industries. The management is highly experienced with clear focus on high opportunity businesses and a strategy of moving away from commodity businesses. Supreme has reported PAT CAGR of 41% and average RoE of 38% over FY09-13. It has a healthy net debt: equity of 0.5x and a lean working capital cycle of 24 days which is lower than that of most of the peers. Intense competition in commodity products and rise in polymer prices are key risks.
Excellent Fundamentals 5
Fundamental Grade
4 3 2 1
Poor Fundamentals
Valuation Grade
Strong Downside Strong Upside
Financial performance We expect revenues to grow at a two-year CAGR of 19% to 47.5 bn in FY15, driven by growth across all segments. We expect the commercial real estate project to contribute 900 mn in FY14 and 1.9 bn in FY15. PAT is expected to grow at a two-year CAGR of 21.4% to 4.3 bn in FY15. RoE and RoCE are expected to remain >30% over the forecast period. Valuation Our discounted cash flow-based fair value estimate for Supreme is 370 per share. The core business (plastics excluding industrial subsidy and commercial real estate) is valued at 353 per share implying P/E multiples of 16x FY14E and 13.4x FY15 core EPS.
SHAREHOLDING PATTERN
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Dec-12 Mar-13 FII Jun-13 DII Sep-13 Others
49.6% 49.6% 49.6% 49.6% 29.3% 8.8% 12.3% 28.9% 7.2% 14.3% 27.5% 7.0% 15.9% 26.6% 7.3% 16.5%
KEY FORECAST
( mn) Operating income EBITDA Adj PAT Adj EPS- EPS growth (%) Dividend yield (%) RoCE (%) RoE (%) PE (x) P/BV (x) EV/EBITDA (x) FY11 24,638 3,566 1,941 15.3 25.6 1.0 31.5 40.4 29.3 10.4 FY12 29,659 4,712 2,408 19.0 24.1 1.3 37.8 38.7 23.6 8.2 12.8 FY13 33,949 5,356 2,901 22.8 20.4 1.7 37.9 36.8 19.6 6.5 11.5 FY14E 40,454 6,073 3,336 26.3 15.0 1.9 35.0 34.0 17.1 5.3 10.1 FY15E 47,496 7,526 4,300 33.9 28.9 2.2 39.1 35.2 13.2 4.2 8.0
Promoter
1-m 12% 3%
12-m 53% 2%
17.4 Note: Supreme has financial year ending June CMP: Current Market Price Source: Company, CRISIL Research estimate
Supreme 9x
5x 11x
7x 13x
CRISIL IERIndependentEquityResearch
Annexure: Financials
Income statement
( mn) Operating income EBITDA EBITDA margin Depreciation EBIT Interest Operating PBT Other income Exceptional inc/(exp) PBT Tax provision Minority interest PAT (Reported) Less: Exceptionals Adjusted PAT FY11 24,638 3,566 14.5% 629 2,938 438 2,500 319 17 2,836 877 1,958 17 1,941 FY12 29,659 4,712 15.9% 725 3,987 578 3,409 149 8 3,567 1,150 2,417 8 2,408 FY13 33,949 5,356 15.8% 817 4,539 552 3,987 244 15 4,246 1,330 0.41 2,916 15 2,901 FY14E 40,454 6,073 15.0% 992 5,081 538 4,543 291 4,834 1,499 3,336 3,336 FY15E 47,496 7,526 15.8% 1,150 6,375 469 5,907 325 6,232 1,932 4,300 4,300
Balance Sheet
( mn) Liabilities Equity share capital Reserves Minorities Net worth Convertible debt Other debt Total debt Deferred tax liability (net) Total liabilities Assets Net fixed assets Capital WIP Total fixed assets Investments Current assets Inventory FY11 FY12 20.4 32.1 24.1 24.1 FY13 14.5 13.7 20.4 20.4 FY14E 19.2 13.4 15.0 15.0 FY15E 17.4 23.9 28.9 28.9 Sundry debtors Loans and advances 22.2 19.9 24.9 24.9 Cash & bank balance Marketable securities Total current assets Total current liabilities Net current assets Intangibles/Misc. expenditure 14.5 7.9 40.4 31.5 32.2 15.9 8.1 38.7 37.8 32.8 15.8 8.5 36.8 37.9 34.1 15.0 8.2 34.0 35.0 31.9 15.8 9.1 35.2 39.1 34.8 Total assets 7,410 378 7,788 916 2,357 1,529 2,417 101 41 6,445 3,741 2,704 7 11,415 7,388 703 8,091 887 2,158 1,712 2,278 92 52 6,292 3,965 2,327 6 11,311 10,200 499 10,699 1,098 3,722 2,031 2,269 199 40 8,262 5,742 2,520 78 14,395 10,208 2,499 12,707 1,359 2,948 2,390 2,427 254 40 8,060 5,768 2,293 78 16,437 13,557 99 13,657 1,647 3,468 2,807 2,850 107 40 9,271 6,643 2,628 78 18,008 254 5,223 5,477 5,143 5,143 795 11,415 254 6,713 6,967 3,511 3,511 833 11,311 4,698 4,698 907 14,395 254 8,535 0 8,790 4,698 4,698 907 16,437 254 10,577 0 10,832 3,498 3,498 907 18,008 254 13,349 0 13,603 FY11 FY12 FY13 FY14E FY15E
Ratios
Growth Operating income (%) EBITDA (%) Adj PAT (%) Adj EPS (%) Profitability EBITDA margin (%) Adj PAT Margin (%) RoE (%) RoCE (%) RoIC (%) Valuations Price-earnings (x) Price-book (x) EV/EBITDA (x) EV/Sales (x) Dividend payout ratio (%) Dividend yield (%) B/S ratios Inventory days Creditors days Debtor days Working capital days Gross asset turnover (x) Net asset turnover (x) Sales/operating assets (x) Current ratio (x) Debt-equity (x) Net debt/equity (x) Interest coverage 44 53 23 34 2.3 3.8 3.6 1.7 0.9 0.9 6.7 34 45 21 29 2.4 4.0 3.7 1.6 0.5 0.5 6.9 50 60 20 24 2.4 3.9 3.6 1.4 0.5 0.5 8.2 35 52 22 19 2.5 4.0 3.5 1.4 0.4 0.4 9.5 35 52 22 17 2.5 4.0 3.6 1.4 0.3 0.2 13.6 29.3 10.4 17.4 2.5 27.9 1.0 23.6 8.2 12.8 2.1 31.5 1.3 19.6 6.5 11.5 1.8 32.7 1.7 17.1 5.3 10.1 1.5 32.2 1.9 13.2 4.2 8.0 1.3 29.5 2.2
Cash flow
( mn) Pre-tax profit Total tax paid Depreciation Working capital changes Net cash from operations Cash from investments Capital expenditure Investments and others Net cash from investments Cash from financing Equity raised/(repaid) Debt raised/(repaid) Dividend (incl. tax) Others (incl extraordinaries) Net cash from financing Change in cash position Closing cash 1,269 (635) 30 664 (85) 101 (1,632) (886) (32) (2,550) (9) 92 1,187 (1,113) 34 109 107 199 (1,294) (0) (1,294) 56 254 (1,200) (1,529) (0) (2,729) (148) 107 (2,666) (264) (2,931) (1,027) 18 (1,009) (3,497) (199) (3,696) (3,000) (261) (3,261) (2,100) (287) (2,387) FY11 2,819 (780) 629 (486) 2,181 FY12 3,559 (1,113) 725 379 3,550 FY13 4,231 (1,256) 817 (99) 3,693 FY14E 4,834 (1,499) 992 283 4,611 FY15E 6,232 (1,932) 1,150 (483) 4,968
Quarterly financials
( mn) Net Sales Change (q-o-q) EBITDA Change (q-o-q) Q1FY13 6,176 -33% 848 -52% 13.7% 390 390 -59% 6.3% 3.1 Q2FY13 8,150 32% 1,194 41% 14.6% 664 664 70% 8.1% 5.2 Q3FY13 9,177 13% 1,343 13% 14.6% 758 758 14% 8.3% 6.0 Q4FY13 10,537 15% 1,971 47% 18.7% 1,089 1,089 44% 10.3% 8.6 Q1FY14 7,051 -33% 920 -53% 13.0% 430 430 -61% 6.1% 3.4
Per share
FY11 Adj EPS () CEPS Book value Dividend () Actual o/s shares (mn) 15.3 20.2 43.1 4.3 127.0 FY12 19.0 24.7 54.8 6.0 127.0 FY13 22.8 29.3 69.2 7.5 127.0 FY14E 26.3 34.1 85.3 8.5 127.0 FY15E 33.9 42.9 107.1 10.0 127.0
EBITDA margin PAT Adj PAT Change (q-o-q) Adj PAT margin Adj EPS
10
47 35
Mumbai-based Time Technoplast Ltd (Time) manufactures polymer-based products under four main segments: industrial packaging (62% of revenues), infrastructure products (17%), automotive products (8%) and lifestyle products (10%). Grading rationale Time is the market leader in the domestic industrial packaging market with ~70% market share. Over the years, it has built strong relationships with more than 500 institutional clients and has ~30 manufacturing facilities, which have enabled it to service clients across India. Over FY11-13, the company has opted for an Asia-focused expansion for its industrial packaging products. It currently has a presence in 10 countries. The penetration of polymer drums in these geographies is low and Time plans to replicate its India strategy in these regions. We expect the established geographies (Bahrain, Taiwan, Thailand and UAE) to drive Times revenues in the near term. The new geographies (China, Egypt, Indonesia, Malaysia, South Korea and Vietnam) are expected to start contributing from FY14 onwards aided by Times strategic vendor status with various global chemical companies. Time was unable to pass on the recent rupee depreciation-led increase in polymer prices completely since the domestic demand is sluggish. We expect raw material prices to remain high and the demand to be muted. Hence, we expect Times overall EBITDA margin to decline by 200 bps over FY13-15 to 14.5%. In Q2FY14, Time started sales of composite cylinders to Reliance Gas in India and some more orders are expected from the non-subsidised LPG market. However, the subsidised domestic LPG cylinders segment, which comprises majority of the domestic market, is still to accept composite cylinders. Also, Time has not been able to secure any large order for its composite cylinders facility located in Bahrain. Times capex is expected to moderate over FY13-15 as the international expansion is complete and the company now plans to focus on improving capacity utilisation rates. Accordingly, return ratios are expected to improve in FY15. Inability to ramp up utilisation rates of the new international capacities and further increase in raw material prices are key risks for the company.
4 3 2 1
Poor Fundamentals
Valuation Grade
Strong Downside Strong Upside
18.7% 8.7% 10.8% 18.7% 8.7% 10.8% 61.9% 61.9%
SHAREHOLDING PATTERN
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Dec-12 Promoter Mar-13 FII Jun-13 DII Sep-13 Others
61.9% 61.9% 19.1% 8.7% 10.4% 19.1% 8.7% 10.4%
Financial performance Revenues are expected to grow at a two-year CAGR of 18% to 24.6 bn in FY15 driven by increase in utilisation of international capacities and sustained growth in the domestic industrial packaging market. PAT is expected to grow at a two-year CAGR of 8% due to pressure on EBITDA margin. Valuation Our discounted cash flow-based fair value estimate for Time is 47 per share. At this value, the implied P/E multiples are 10.9x FY14E and 8.2x FY15E EPS.
KEY FORECAST
( mn) Operating income EBITDA Adj PAT Adj EPS- EPS growth (%) Dividend yield (%) RoCE (%) RoE (%) PE (x) P/BV (x) EV/EBITDA (x) CMP: Current Market Price Source: Company, CRISIL Research estimate FY11 12,591 2,364 1,077 5.1 18.5 1.6 16.8 17.1 6.8 1.1 5.5 FY12 15,095 2,444 898 4.3 (17.0) 1.3 13.3 12.2 8.2 0.9 6.1 FY13 17,757 2,920 1,035 4.9 15.2 1.3 13.8 12.5 7.1 0.8 5.3 FY14E 21,369 3,029 909 4.3 (12.2) 1.3 12.4 9.9 8.1 0.8 5.3 FY15E 24,639 3,567 1,201 5.7 32.1 1.6 13.8 11.8 6.1 0.7 4.6
1-m 5% 3%
12-m -23% 2%
Time 10x
6x 12x
8x 14x
11
CRISIL IERIndependentEquityResearch
Annexure: Financials
Income statement
( m n) Operating income EBITDA EBITDA margin Depreciation EBIT Interest Operating PBT Other income Exceptional inc/(exp) PBT Tax provision Minority interest PAT (Reported) Less: Exceptionals Adjusted PAT FY11 12,591 2,364 18.8% 440 1,924 451 1,473 19 54 1,545 356 59 1,131 54 1,077 4% FY11 25.9 21.1 18.5 18.5 FY12 15,095 2,444 16.2% 556 1,888 685 1,203 26 0 1,230 308 23 898 0 898 FY13 17,757 2,920 16.4% 675 2,245 886 1,359 49 (9) 1,400 341 33 1,026 (9) 1,035 FY14E 21,369 3,029 14.2% 849 2,180 960 1,220 27 1,247 299 39 909 909 FY15E 24,639 3,567 14.5% 961 2,606 991 1,615 27 1,642 394 47 1,201 1,201
Balance Sheet
( m n) Liabilities Equity share capital Reserves Minorities Net w orth Convertible debt Other debt Total debt Deferred tax liability (net) Total liabilities Assets Net f ixed assets Capital WIP Total fixed assets Investm ents Current assets Inventory Sundry debtors Loans and advances Cash & bank balance Marketable securities Total current assets Total current liabilities Net current assets Intangibles/Misc. expenditure Total assets FY11 209 6,230 414 6,853 5,891 5,891 287 13,031 5,951 1,191 7,143 2,589 2,503 1,071 537 6,700 2,061 4,639 1,249 13,031 FY12 210 7,081 569 7,861 7,685 7,685 339 15,885 7,650 1,349 8,998 3,082 3,208 1,376 664 3 8,334 2,708 5,626 1,260 15,885 FY13 210 7,976 569 8,755 8,246 8,246 369 17,370 8,753 1,475 10,228 3,617 3,629 1,289 535 4 9,073 3,181 5,892 1,249 17,370 FY14E 210 8,771 608 9,589 8,646 8,646 369 18,604 9,654 725 10,379 4,332 4,367 1,710 515 4 10,927 3,951 6,976 1,249 18,604 FY15E 210 9,835 655 10,700 8,796 8,796 369 19,865 10,193 475 10,668 4,995 5,035 1,971 483 4 12,488 4,540 7,948 1,249 19,865
Ratios
Grow th Operating income (%) EBITDA (%) Adj PAT (%) Adj EPS (%) Profitability EBITDA margin (%) Adj PAT Margin (%) RoE (%) RoCE (%) RoIC (%) Valuations Price-earnings (x) Price-book (x) EV/EBITDA (x) EV/Sales (x) Dividend payout ratio (%) Dividend yield (%) B/S ratios Inventory days Creditors days Debtor days Working capital days Gross asset turnover (x) Net asset turnover (x) Sales/operating assets (x) Current ratio (x) Debt-equity (x) Net debt/equity (x) Interest coverage
Cash flow
( m n) Pre-tax prof it Total tax paid Depreciation Working capital changes Net cash from operations Cash from investments Capital expenditure Investments and others Net cash from investm ents Cash from financing Equity raised/(repaid) Debt raised/(repaid) Dividend (incl. tax) Others (incl extraordinaries) Net cash from financing Change in cash position Closing cash FY11 1,492 (280) 440 (764) 887 (2,219) (2,219) 0 1,493 (136) 81 1,437 105 537 FY12 1,229 (256) 556 (858) 672 (2,423) (3) (2,425) 15 1,795 (114) 186 1,881 127 664 FY13 1,408 (311) 675 (394) 1,378 (1,894) (1) (1,895) 560 (115) (58) 388 (129) 535 FY14E 1,247 (299) 849 (1,104) 693 (1,000) (1,000) 400 (114) (0) 286 (21) 515 FY15E 1,642 (394) 961 (1,004) 1,205 (1,250) (1,250) 150 (137) (0) 13 (32) 483
Quarterly financials
( m n) Net Sales Change (q-o-q) EBITDA Change (q-o-q) EBITDA margin PAT Adj PAT Change (q-o-q) Adj PAT m argin Adj EPS Q2FY13 4,319 7% 740 12% 17.1% 267 267 14% 6.2% 1.3 Q3FY13 4,411 2% 772 4% 17.5% 291 291 9% 6.6% 1.4 Q4FY13 5,206 18% 741 -4% 14.2% 242 242 -17% 4.6% 1.2 Q1FY14 4,892 -6% 695 -6% 14.2% 190 190 -21% 3.9% 0.9 Q2FY14 5,323 9% 748 8% 14.1% 219 219 15% 4.1% 1.0
Per share
Adj EPS () CEPS Book value Dividend () Actual o/s shares (mn) FY11 5.1 7.2 32.7 0.6 209 FY12 4.3 6.9 37.4 0.5 210 FY13 4.9 8.1 41.7 0.5 210 FY14E 4.3 8.4 45.6 0.5 210 FY15E 5.7 10.3 50.9 0.6 210
12
126 74
CFV MATRIX
Excellent Fundamentals 5 4 3 2 1 Poor Fundamentals 1 2 3 4 5
gradechips and PET films. Grading rationale JBF is in the process of backward integrating into manufacturing PTA (purified terephthalic acid), the key raw material for chips. This is a positive step for JBF as it will ensure consistent supply of PTA, which will reduce logistics cost, enhance margins, lower working capital requirement and improve its competitive position in the industry. JBF continues to focus on the de-risking strategy; after forward integrating into filament yarn (POY) it has shifted a portion of its fibre grade capacity to bottle grade capacity, owing to reduction in market size of the former. Moreover, at a five-year ~5% CAGR, PET is one of the fastest growing polyester inputs globally. JBF plans to expand its PET capacity by 390,000 tonnes by setting up a new plant in Belgium adjacent to British Petroleums PTA plant, thereby giving it entry into European markets where it does not supply bottle grade chips. Proximity to BP's PTA facility will ensure continuous supply of PTA with logistical cost savings. In UAE, JBF is expanding the film capacity by setting up a 90,000 TPAPET plant in Bahrain. The Bahrain capacity will be exclusively for exports and will cater to the US market where it will have a competitive advantage because of Bahrains free trade agreement (FTA) with the US. Key risks: Delay in execution of the projects and cost overruns are key risks for the company. Profitability is likely to be under pressure as polyester and PET industries are expected to face oversupply globally. Financial performance We expect revenues to increase at a two-year CAGR of 14.5% to 97.8 bn in FY15. EBITDA margin is expected to expand by 80 bps to 10.1% in FY15. We expect reduction in derivative losses to improve profitability and return ratios. EPS is expected to grow at a two-year CAGR of 52% to 30.7 Valuation Our discounted cash flow-based outstanding fair value estimate for JBF is 126 per share. At this value, the implied P/E multiples are 10.6x FY14E and 4.1x FY15E EPS.
Valuation Grade
Strong Downside
SHAREHOLDING PATTERN
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Dec-12 Mar-13 FII Jun-13 DII Sep-13 Others Promoter
44.5% 47.0% 48.6% 55.9% 16.5% 7.8% 12.8% 7.0% 11.8% 7.6% 31.3% 33.2% 32.0% 22.9% 9.9% 11.2%
KEY FORECAST
(mn) Operating income EBITDA Adj net income Adj EPS- EPS growth (%) Dividend yield (%) RoCE (%) RoE (%) PE (x) P/BV (x) EV/EBITDA (x) CMP: Current Market Price Source: Company, CRISIL Research estimate FY11 64,658 9,629 5,408 75.5 147.4 5.9 28.6 40.7 1.8 0.7 2.6 FY12 71,772 7,141 1,948 27.1 (64.2) 6.0 13.9 12.9 5.0 0.6 4.9 FY13 74,551 6,957 968 13.3 (50.8) 1.2 9.2 5.7 7.9 0.4 6.6 FY14 83,030 7,460 858 13.1 (1.4) 4.0 7.1 5.0 9.6 0.5 9.6 FY15 97,758 9,827 2,002 30.7 133.4 6.7 7.6 11.3 4.1 0.4 8.7
Strong Upside
12-m -42% 2%
-6% 3%
JBF 6x
2x 8x
4x 10x
13
CRISIL IERIndependentEquityResearch
Balance Sheet
( m n) Liabilities Equity share capital Reserves Minorities Net w orth Convertible debt Other debt Total debt Def erred tax liability (net) Total liabilities Assets Net fixed assets Capital WIP Total fixed assets Investm ents Current assets Inventory Sundry debtors Loans and advances Cash & bank balance Marketable securities Total current assets Total current liabilities Net current assets Intangibles/Misc. expenditu Total assets FY11 717 13,526 14,243 18,102 18,102 1,430 33,775 21,093 2,708 23,800 1,280 7,344 7,192 3,424 2,350 20,310 12,519 7,791 905 33,775 FY12 720 15,340 16,060 28,774 28,774 1,223 46,058 27,607 3,814 31,420 1,877 7,918 7,617 3,900 3,616 23,051 11,314 11,737 1,025 46,058 FY13 726 16,873 17,600 41,936 41,936 1,581 61,116 32,141 10,597 42,737 3,762 9,231 10,803 5,554 3,462 29,049 15,537 13,512 1,105 61,116 FY14E 651 16,378 17,029 64,482 64,482 1,581 83,092 40,867 28,706 69,573 2,500 10,237 9,959 5,397 835 26,428 16,513 9,915 1,105 83,092 FY15E 651 17,731 18,382 78,158 78,158 1,581 98,121 51,456 33,709 85,165 1,500 10,713 11,117 5,312 1,331 28,473 18,120 10,352 1,105 98,121
Ratios
FY11 Grow th Operating income (%) EBITDA (%) Adj PAT (%) Adj EPS (%) Profitability EBITDA margin (%) Adj PAT Margin (%) RoE (%) RoCE (%) RoIC (%) Valuations Price-earnings (x) Price-book (x) EV/EBITDA (x) EV/Sales (x) Dividend payout ratio (%) Dividend yield (%) B/S ratios Inventory days Creditors days Debtor days Working capital days Gross asset turnover (x) Net asset turnover (x) Sales/operating assets (x) Current ratio (x) Debt-equity (x) Net debt/equity (x) Interest coverage (EBITDA/Interes Interest coverage (x) 14.9 8.4 40.7 28.6 30.2 10.0 2.7 12.9 13.9 23.7 9.3 1.3 5.7 9.2 11.5 9.0 1.0 5.0 7.1 8.3 10.1 2.0 11.3 7.6 7.8 31.0 104.0 184.8 147.4 FY12 11.0 (25.8) (64.0) (64.2) FY13 3.9 (2.6) (50.3) (50.8) FY14E 11.4 7.2 (11.4) (1.4) FY15E 17.7 31.7 133.4 133.4
Cash flow
( m n) Pre-tax prof it Total tax paid Depreciation Working capital changes Net cash from operations Cash from investm ents Capital expenditure Investments and others Net cash from investm ents Cash from financing Equity raised/(repaid) Debt raised/(repaid) Dividend (incl. tax) Others (incl extraordinaries) Net cash from financing Change in cash position Closing cash FY11 6,010 (510) 1,289 (1,596) 5,194 (4,830) 30 (4,799) 1,269 4,459 (666) (4,104) 957 1,352 2,350 FY12 1,744 (2) 1,784 (2,681) 845 (9,523) (597) (10,121) 36 10,672 (678) 511 10,541 1,265 3,616 FY13 1,338 (13) 2,167 (1,929) 1,563 (13,564) (1,886) (15,450) 60 13,161 (111) 623 13,733 (154) 3,462 FY14E 1,009 (151) 2,448 970 4,276 (29,284) 1,262 (28,022) (732) 22,547 (382) (314) 21,119 (2,627) 835 FY15E 2,356 (353) 3,094 58 5,155 (18,686) 1,000 (17,686) 13,676 (649) 13,027 496 1,331
Quarterly financials
( m n) Net Sales Change (q-o-q) EBITDA Change (q-o-q) EBITDA m argin PAT Adj PAT Change (q-o-q) Adj PAT m argin Adj EPS Q2FY13 18,108 0.7% 1,721 -9% 9.5% 494 494 46.7% 2.7% 6.8 Q3FY13 17,422 -4% 1,772 3% 10% 298 298 -40% 2% 4.1 Q4FY13 21,047 21% 1,754 -1% 8% 5 242 19% 1% 3.3 Q1FY14 20,950 0% 1,590 -9% 8% (410) (410) NM -2% (5.6) Q2FY14 22,444 7.1% 2,055 29% 9% (39) (39) NM -0.2% (0.6)
Per share
Adj EPS () CEPS Book value Dividend ( ) Actual o/s shares (mn) FY11 75.5 93.5 198.8 8.0 71.7 FY12 27.1 51.8 223.0 8.1 72.0 FY13 13.3 43.2 242.3 1.3 72.6 FY14E 13.1 50.6 260.8 5.0 65.3 FY15E 30.7 78.1 281.5 8.5 65.3
14
187 107
CFV MATRIX
Excellent Fundamentals 5 4 3 2 1 Poor Fundamentals 1 2 3 4 5
Valuation Grade
Strong Downside Strong Upside
24.1% 8.7% 24.1% 8.7% 24.0% 8.7% 67.2% 67.2% 67.3%
SHAREHOLDING PATTERN
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Dec-12 Promoter Mar-13 FII Jun-13 DII Sep-13 Others
67.1% 8.7% 24.2%
KEY FORECAST
( mn) Operating income EBITDA Adj net income Adj EPS- EPS growth (%) Dividend yield (%) RoCE (%) RoE (%) PE (x) P/BV (x) EV/EBITDA (x) CMP: Current Market Price Source: Company, CRISIL Research estimate FY11 16,593 2,679 1,829 52.2 63.9 3.4 22.5 28.2 3.0 0.8 2.5 FY12 19,820 1,467 310 8.8 (80.0) 4.8 8.2 4.24 12.3 0.5 5.6 FY13 24,411 1,547 629 18.0 323.0 5.9 5.1 7.9 4.9 0.4 13.9 FY14 40,818 3,054 1,239 35.4 23.3 6.4 7.8 13.9 3.1 0.4 8.1 FY15 67,552 4,906 1,758 50.2 41.9 8.2 11.6 17.3 2.2 0.3 5.1
Oct-09
Oct-10
Nov-11
Nov-12
May-08
Dhunseri 6x
1x 9x
3x 12x
Dec-13
Jan-08
Jan-09
Jun-09
Feb-10
Jun-10
Feb-11
Mar-12
Mar-13
Jul-11
Sep-08
Jul-12
Aug-13
15
CRISIL IERIndependentEquityResearch
Balance Sheet
( m n) Liabilities Equity share capital Reserves Minorities Net w orth Convertible debt Other debt Total debt Deferred tax liability (net) Total liabilities Assets Net fixed assets Capital WIP Total fixed assets Investments Current assets Inventory Sundry debtors Loans and advances Cash & bank balance Marketable securities Total current assets Total current liabilities Net current assets Intangibles/Misc. expenditure Total assets FY11 350 6,785 7,135 4,098 4,098 671 11,904 5,857 483 6,339 612 1,824 1,722 2,454 2,905 8,905 4,001 4,904 49 11,904 FY12 350 7,130 7,481 8,997 8,997 724 17,201 5,954 5,447 11,401 339 2,276 2,517 1,419 4,064 590 10,867 5,444 5,424 37 17,201 FY13 350 7,411 726 8,487 20,160 20,160 901 29,548 9,935 7,000 16,935 211 4,772 5,324 3,149 2,184 330 15,759 3,556 12,203 199 29,548 FY14E 350 8,403 561 9,314 22,660 22,660 1,008 32,982 17,993 1,079 19,072 211 6,710 8,387 4,082 1,943 330 21,452 7,932 13,519 179 32,982 FY15E 350 9,844 860 11,054 22,090 22,090 1,214 34,358 18,372 754 19,126 211 8,328 12,955 4,729 1,609 330 27,951 13,089 14,862 159 34,358
Ratios
FY11 Grow th Operating income (%) EBITDA (%) Adj PAT (%) Adj EPS (%) Profitability EBITDA margin (%) Adj PAT Margin (%) RoE (%) RoCE (%) RoIC (%) Valuations Price-earnings (x) Price-book (x) EV/EBITDA (x) EV/Sales (x) Dividend payout ratio (%) Dividend yield (%) B/S ratios Inventory days Creditors days Debtor days Working capital days Gross asset turnover (x) Net asset turnover (x) Sales/operating assets (x) Current ratio (x) Debt-equity (x) Net debt/equity (x) Interest coverage 43.3 132.1 152.8 152.8 FY12 19.4 (45.2) (83.1) (83.1) FY13 23.2 5.4 103.0 103.0 FY14E 67.2 97.5 96.9 96.9 FY15E 65.5 60.6 41.9 41.9
Cash flow
( m n) Pre-tax profit Total tax paid Depreciation Working capital changes Net cash from operations Cash from investments Capital expenditure Investments and others Net cash from investments Cash from financing Equity raised/(repaid) Debt raised/(repaid) Dividend (incl. tax) Others (incl extraordinaries) Net cash from financing Change in cash position Closing cash FY11 2,497 (379) 312 (846) 1,584 (894) 203 (690) 233 123 (184) (590) (418) 476 2,905 FY12 435 (72) 333 1,230 1,926 (5,384) (317) (5,701) 4,899 (183) 219 4,934 1,159 4,064 FY13 989 (51) 401 (8,919) (7,580) (6,097) 389 (5,708) (148) 11,163 (183) 576 11,408 (1,880) 2,184 FY14E 1,343 (161) 702 (1,558) 326 (2,820) (2,820) 0 2,500 (248) 0 2,252 (241) 1,943 FY15E 2,572 (309) 1,129 (1,676) 1,716 (1,163) (1,163) (570) (316) (886) (334) 1,609
Per share
Adj EPS () CEPS Book value Dividend () Actual o/s shares (mn) FY11 52.2 61.1 203.7 5.2 35.0 FY12 8.8 18.4 213.5 5.2 35.0 FY13 18.0 29.4 242.3 5.2 35.0 FY14E 35.4 55.4 265.9 7.1 35.0 FY15E 50.2 82.4 315.5 9.0 35.0
16
60 44
Fundamental Grade
Mumbai-based Hitech Plast Ltd (Hitech) is a leading manufacturer of polymer-based containers for the paints, FMCG, agrochemicals, lubricants and pharmaceutical industries. The paint-container segment contributed 58% to consolidated revenues in FY13 and the balance was contributed by the non-paint container segment. Grading rationale Hitech is one of the largest manufacturers of rigid polymer-based containers for the paint and FMCG industries. It has 15 facilities spread across North, West and South India. The company is expected to benefit from the strong growth prospects of the end-user industries in the long term.
5 4 3 2 1
Poor Fundamentals
Paint industry: Growth is expected to be driven by increase in penetration of paints (especially in rural India), rise in construction activity and disposable income. FMCG industry: Rise in income levels, increased preference for packaged products and organised retailing are expected to drive growth in the FMCG industry.
Valuation Grade
Strong Downside
Hitech is focussing on expanding its client base across both the paint and FMCG segments to mitigate the client concentration risk. After growing at 24% CAGR over FY08-11, Hitechs revenue growth slowed down to 13% over FY12-13 due to (a) sluggish demand from paints and FMCG industries, (b) shortterm plant related issues. We expect revenue growth to pick up in FY15 led by revival in end-user demand. The company has implemented cost-saving measures and also plans to consolidate plants located in close proximity, which is likely to aid EBITDA margin in the long term. Key risks:
Rising competition from the organised players in the paint-container segment. Increase in raw material prices - as Hitech is able to pass on the increase with a lag, its EBITDA margin is impacted in a cost inflationary environment.
Financial performance Revenues are expected to grow at a two-year CAGR of 12% to 5.5 bn in FY15 driven by the paint container segment. EBITDA margin is expected to expand to 11.2% in FY15 from 10.6% in FY13. PAT is expected to increase to 143 mn in FY15 from 90 mn in FY13. Valuation Our discounted cash flow-based fair value estimate for Hitech is 60 per share. At this value, the implied P/E multiples are 11.9x FY14E and 5.5x FY15E EPS.
SHAREHOLDING PATTERN
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Dec-12 Mar-13 DII Jun-13 Sep-13 Others
66.7% 66.7% 66.7% 66.7% 29.6% 3.8% 29.6% 3.8% 29.6% 3.8% 29.6% 3.8%
KEY FORECAST
( mn) Operating income EBITDA Adj PAT Adj EPS- EPS growth (%) Dividend yield (%) RoCE (%) RoE (%) PE (x) P/BV (x) EV/EBITDA (x) CMP: Current Market Price; Source: Company, CRISIL Research estimate FY11 3,451 466 142 10.8 (4.1) 3.7 18.7 14.4 4.1 0.7 3.8 FY12 3,861 460 104 7.9 (26.5) 3.7 14.0 9.3 5.5 0.7 4.2 FY13 4,398 468 90 6.9 (13.2) 3.7 12.7 7.5 6.4 0.6 4.0 FY14E 4,716 491 67 5.1 (26.2) 2.4 12.8 5.3 8.6 0.6 3.9 FY15E 5,541 622 143 10.8 114.0 3.8 17.1 10.4 4.0 0.5 3.1
Promoter
1-m 11% 3%
Strong Upside
12-m -18% 2%
Hitech 9x
5x 11x
7x 13x
17
CRISIL IERIndependentEquityResearch
Annexure: Financials
Income statement
( mn) Operating income EBITDA EBITDA margin Depreciation EBIT Interest Operating PBT Other income Exceptional inc/(exp) PBT Tax provision Minority interest PAT (Reported) Less: Exceptionals Adjusted PAT FY11 3,451 466 13.5% 126 340 123 217 5 2 224 63 17 144 2 142 FY12 3,861 460 11.9% 154 307 175 131 7 2 141 37 (2) 106 2 104 FY13 4,398 468 10.6% 173 295 183 112 15 126 23 13 90 90 FY14E 4,716 491 10.4% 192 299 170 129 4 (8) 126 45 22 59 (8) 67 FY15E 5,541 622 11.2% 203 419 161 258 4 263 89 31 143 143
Balance Sheet
( mn) Liabilities Equity share capital Reserves Net worth Minorities Convertible debt Other debt Total debt Deferred tax liability (net) Total liabilities Assets Net fixed assets Capital WIP Total fixed assets Investments Current assets Inventory FY11 FY12 11.9 (1.3) (26.5) (26.5) FY13 13.9 1.6 (13.2) (13.2) FY14E 7.2 4.9 (26.2) (26.2) FY15E 17.5 26.8 114.0 114.0 Sundry debtors Loans and advances 31.0 14.0 (4.1) (4.1) Cash & bank balance Marketable securities Total current assets Total current liabilities Net current assets Intangibles/Misc. expenditure 13.5 4.1 14.4 18.7 16.3 11.9 2.7 9.3 14.0 13.4 10.6 2.1 7.5 12.7 13.4 10.4 1.4 5.3 12.8 11.5 11.2 2.6 10.4 17.1 14.1 Total assets 1,093 100 1,193 1 424 578 122 57 1,181 313 868 33 2,095 1,242 133 1,375 1 382 624 152 74 12 1,243 259 984 32 2,393 1,440 27 1,467 270 615 191 48 16 1,139 296 843 32 2,342 1,348 27 1,375 349 711 236 49 16 1,360 321 1,039 32 2,446 1,295 27 1,322 410 835 277 46 16 1,583 374 1,210 32 2,564 132 665 797 280 963 963 56 2,095 132 749 880 278 1,182 1,182 52 2,393 132 814 946 292 1,047 1,047 57 2,342 132 857 989 313 1,087 1,087 57 2,446 132 974 1,106 344 1,057 1,057 57 2,564 FY11 FY12 FY13 FY14E FY15E
Ratios
Growth Operating income (%) EBITDA (%) Adj PAT (%) Adj EPS (%) Profitability EBITDA margin (%) Adj PAT Margin (%) RoE (%) RoCE (%) RoIC (%) Valuations Price-earnings (x) Price-book (x) EV/EBITDA (x) EV/Sales (x) Dividend payout ratio (%) Dividend yield (%) B/S ratios Inventory days Creditors days Debtor days Working capital days Gross asset turnover (x) Net asset turnover (x) Sales/operating assets (x) Current ratio (x) Debt-equity (x) Net debt/equity (x) Interest coverage 55 34 56 75 2.2 3.7 3.2 3.8 0.9 0.8 2.8 44 19 54 81 2.0 3.3 3.0 4.8 1.0 0.9 1.8 27 20 47 70 1.9 3.3 3.1 3.8 0.8 0.8 1.6 34 20 51 68 1.9 3.4 3.3 4.2 0.8 0.8 1.8 34 20 51 70 2.1 4.2 4.1 4.2 0.7 0.7 2.6 4.1 0.7 3.8 0.5 17.1 3.7 5.5 0.7 4.2 0.5 23.0 3.7 6.4 0.6 4.0 0.4 27.3 3.7 8.6 0.6 3.9 0.4 23.3 2.4 4.0 0.5 3.1 0.3 15.4 3.8
Cash flow
( mn) Pre-tax profit Total tax paid Depreciation Working capital changes Net cash from operations Cash from investments Capital expenditure Investments and others Net cash from investments Cash from financing Equity raised/(repaid) Debt raised/(repaid) Dividend (incl. tax) Others (incl extraordinaries) Net cash from financing Change in cash position Closing cash 266 (25) 45 286 (4) 57 219 (25) 5 200 17 74 (135) (25) (0) (160) (26) 48 40 (14) (10) 16 1 49 (30) (22) (4) (56) (3) 46 (377) (377) (335) (12) (347) (264) (3) (267) (100) (100) (150) (150) FY11 222 (57) 126 (204) 87 FY12 138 (41) 154 (87) 164 FY13 126 (18) 173 119 401 FY14E 134 (45) 192 (195) 85 FY15E 263 (89) 203 (174) 203
Quarterly financials
( mn) Net Sales Change (q-o-q) EBITDA Change (q-o-q) EBITDA margin PAT Adj PAT Change (q-o-q) Adj PAT margin Adj EPS Q2FY13 1,111 -2% 145 12% 13.1% 33 33 39% 3.0% 2.5 Q3FY13 1,049 -6% 98 -32% 9.4% 24 24 -28% 2.3% 1.8 Q4FY13 1,096 4% 88 -10% 8.0% 10 10 -58% 0.9% 0.8 Q1FY14 1,116 2% 114 30% 10.2% 10 17 76% 1.6% 1.3 Q2FY14 1,174 5% 124 9% 10.6% 15 15 -15% 1.3% 1.1
Per share
FY11 Adj EPS () CEPS Book value Dividend () Actual o/s shares (mn) 10.8 20.3 60.5 1.6 13.2 FY12 7.9 19.6 66.8 1.6 13.2 FY13 6.9 20.0 71.8 1.6 13.2 FY14E 5.1 19.6 75.1 1.0 13.2 FY15E 10.8 26.2 84.0 1.7 13.2
18
CRISIL IERIndependentEquityResearch
Analytical Contacts
Sandeep Sabharwal Prasad Koparkar Binaifer Jehani Manoj Mohta Sudhir Nair Mohit Modi Jiju Vidyadharan Ajay D'Souza Ajay Srinivasan Rahul Prithiani Senior Director, Capital Markets Senior Director, Industry & Customised Research Director, Customised Research Director, Customised Research Director, Customised Research Director, Equity Research Director, Funds & Fixed Income Research Director, Industry Research Director, Industry Research Director, Industry Research +91 22 4097 8052 +91 22 3342 3137 +91 22 3342 4091 +91 22 3342 3554 +91 22 3342 3526 +91 22 4254 2860 +91 22 3342 8091 +91 22 3342 3567 +91 22 3342 3530 +91 22 3342 3574 sandeep.sabharwal@crisil.com prasad.koparkar@crisil.com binaifer.jehani@crisil.com manoj.mohta@crisil.com sudhir.nair@crisil.com mohit.modi@crisil.com jiju.vidyadharan@crisil.com ajay.dsouza@crisil.com ajay.srinivasan@crisil.com rahul.prithiani@crisil.com
Business Development
Hani Jalan Prosenjit Ghosh Director, Capital Markets Director, Industry & Customised Research +91 22 3342 3077 +91 22 3342 8008 hani.jalan@crisil.com prosenjit.ghosh@crisil.com
20
Largest team of economy and industry research analysts in India Coverage on 70 industries and 139 sub-sectors; provide growth forecasts, profitability analysis, emerging trends, expected investments, industry structure and regulatory frameworks 90 per cent of Indias commercial banks use our industry research for credit decisions Special coverage on key growth sectors including real estate, infrastructure, logistics, and financial services Inputs to Indias leading corporates in market sizing, demand forecasting, and project feasibility Published the first India-focused report on Ultra High Net-worth Individuals All opinions and forecasts reviewed by a highly qualified panel with over 200 years of cumulative experience
Largest and most comprehensive database on Indias debt market, covering more than 15,000 securities Largest provider of fixed income valuations in India Value more than 53 trillion (USD 960 billion) of Indian debt securities, comprising outstanding securities Sole provider of fixed income and hybrid indices to mutual funds and insurance companies; we maintain 12 standard indices and over 100 customised indices Ranking of Indian mutual fund schemes covering 70 per cent of assets under management and 4.7 trillion (USD 85 billion) by value Retained by Indias Employees Provident Fund Organisation, the worlds largest retirement scheme covering over 60 million individuals, for selecting fund managers and monitoring their performance
Largest independent equity research house in India, focusing on small and mid-cap companies; coverage exceeds 125 companies Released company reports on 1,442 companies listed and traded on the National Stock Exchange; a global first for any stock exchange First research house to release exchange-commissioned equity research reports in India Assigned the first IPO grade in India
Our Office
Ahmedabad 706, Venus Atlantis Nr. Reliance Petrol Pump Prahladnagar, Ahmedabad, India Phone: +91 79 4024 4500 Fax: +91 79 2755 9863 Hyderabad 3rd Floor, Uma Chambers Plot No. 9&10, Nagarjuna Hills, (Near Punjagutta Cross Road) Hyderabad - 500 482, India Phone: +91 40 2335 8103/05 Fax: +91 40 2335 7507 Kolkata Horizon, Block 'B', 4th Floor 57 Chowringhee Road Kolkata - 700 071, India Phone: +91 33 2289 1949/50 Fax: +91 33 2283 0597
Bengaluru W-101, Sunrise Chambers, 22, Ulsoor Road, Bengaluru - 560 042, India Phone: +91 80 2558 0899 +91 80 2559 4802 Fax: +91 80 2559 4801 Chennai Thapar House, 43/44, Montieth Road, Egmore, Chennai - 600 008, India Phone: +91 44 2854 6205/06 +91 44 2854 6093 Fax: +91 44 2854 7531 Gurgaon Plot No. 46 Sector 44 Opp. PF Office Gurgaon - 122 003, India Phone: +91 124 6722 000
Pune 1187/17, Ghole Road, Shivaji Nagar, Pune - 411 005, India Phone: +91 20 2553 9064/67 Fax: +91 20 4018 1930
YouTube
CRISIL Limited CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai 400076. India Phone: +91 22 3342 3000 | Fax: +91 22 3342 8088 www.crisil.com